David
Santamaría Velilla
Universidad de Salamanca
Salamanca, EspañaPublications en collaboration avec des chercheurs de Universidad de Salamanca (4)
2024
-
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy
Nature, Vol. 629, Núm. 8013, pp. 919-926
-
In vivo vulnerabilities to GPX4 and HDAC inhibitors in drug-persistent versus drug-resistant BRAFV600E lung adenocarcinoma
Cell Reports Medicine, Vol. 5, Núm. 8
-
Novel RAF-directed approaches to overcome current clinical limits and block the RAS/RAF node
Molecular Oncology, Vol. 18, Núm. 6, pp. 1355-1377
-
RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockade
Nature Communications, Vol. 15, Núm. 1